Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Everest Organics Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹259.50 |
|---|---|
| Day's Range | ₹256.00 - ₹275.90 |
| Open | ₹268.00 |
| 52 Week Range | ₹197.00 - ₹536.40 |
| Volume | 1,640 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 4.26 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 42.60 |
| TTM EPS (₹) | 6.00 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 3.41 |
| PAT Margin (%) | -0.71 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 1.76 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 420.51 | 1972.41 |
| Expenses | N/A | N/A |
| PBT | 11.5 | 6.1 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 11.4 | 1.39 |
About Everest Organics Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | Sri Kakarlapudi Sirisha |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,37,734.67 | 1,863.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,80,311.57 | 6,947.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,45,369.09 | 4,417.65 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,044.98 | 8,113.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,07,204.87 | 1,434.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,05,592.45 | 1,302.80 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,01,293.89 | 2,255.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 99,791.55 | 1,052.50 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 99,384.29 | 2,457.60 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 94,480.34 | 991.30 | 835.50 - 835.50 |
No Records Found
Latest News
Everest Organics informs about press release
Everest Organics informs about closure of trading window
Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended SEBI (‘PIT Regulations’) and in terms of Company's Code of Conduct, Everest Organics has informed that the trading window for dealing in the Company's securities by its Designated persons and their Immediate Relatives will remain closed from Wednesday, April 01, 2026 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ending March 31, 2026. Further, the date of the Board Meeting for consideration and approval of Audited Financial Results of the Company for the quarter and financial year ending March 31, 2026 shall be intimated to the Stock Exchange in due course of time.
The above information is a part of company’s filings submitted to BSE.
Everest Organics informs about updates
Caplin Point Laboratories informs about outcome of board meeting
Shilpa Medicare submits analyst meet intimation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Everest Organics Ltd. is ₹259.50 as of 2026-05-14.
The market capitalisation of Everest Organics Ltd. is ₹248.30 as of 2026-05-13.
The 1-year return of Everest Organics Ltd. is -127.55% as of 2025-05-13.
The P/E ratio of Everest Organics Ltd. is 0.00 as of 2026-05-14.
The 52-week high and low of Everest Organics Ltd. are ₹536.40 and ₹197.00, respectively, as of 2026-05-14.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
